EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

153 hedge funds and large institutions have $337M invested in Eagle Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 47 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
-10
Holders Change %
-6.13%
% of All Funds
2.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
63
Reduced
47
Closed
32
Calls
$3.6M
Puts
–
Net Calls
+$3.6M
Net Calls Change
+$3.6M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
$65.5M
2
State Street
State Street
Massachusetts
$26.7M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
$8.22M
4
Citadel Advisors
Citadel Advisors
Florida
$4.89M
5
TCM
Tang Capital Management
California
$3.14M

Top Sellers

1
Millennium Management
Millennium Management
New York
$4.35M
2
FP
Foundry Partners
Minnesota
$0
3
GC
Globeflex Capital
California
$0
4
Allspring Global Investments
Allspring Global Investments
North Carolina
$2.33M
5
E
Ergoteles
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AQR Capital Management
26
AQR Capital Management
Connecticut
$2.53M +$1.18M +44,599 +87%
Allspring Global Investments
27
Allspring Global Investments
North Carolina
$2.33M -$3.17M -119,997 -58%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.05M -$151K -5,707 -7%
SEI Investments
29
SEI Investments
Pennsylvania
$1.97M +$911K +34,494 +86%
Principal Financial Group
30
Principal Financial Group
Iowa
$1.88M -$290K -10,970 -13%
Man Group
31
Man Group
United Kingdom
$1.82M +$1.82M +68,686 New
Invesco
32
Invesco
Georgia
$1.79M +$10.6K +403 +0.6%
Prudential Financial
33
Prudential Financial
New Jersey
$1.73M -$152K -5,760 -8%
Nuveen Asset Management
34
Nuveen Asset Management
Illinois
$1.72M -$78.6K -2,976 -4%
ETM
35
Euclidean Technologies Management
Washington
$1.65M +$1.65M +62,263 New
Pacer Advisors
36
Pacer Advisors
Pennsylvania
$1.56M +$1.56M +59,189 New
Citigroup
37
Citigroup
New York
$1.54M +$822K +31,113 +114%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.51M +$964K +36,475 +175%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$1.42M -$1.16M -43,970 -45%
CCIA
40
Campbell & Co Investment Adviser
Maryland
$1.26M +$1.13M +42,840 +877%
William Blair & Company
41
William Blair & Company
Illinois
$1.12M – – –
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.05M -$8.03K -304 -0.8%
Barclays
43
Barclays
United Kingdom
$1.03M +$935K +35,373 +1,028%
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$1.01M +$1.01M +38,330 New
Bank of America
45
Bank of America
North Carolina
$939K +$852K +32,252 +981%
SGI
46
Summit Global Investments
Utah
$907K +$15.5K +587 +2%
HIM
47
Hillsdale Investment Management
Ontario, Canada
$889K – – –
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$855K +$121K +4,584 +16%
ETC
49
Exchange Traded Concepts
Oklahoma
$852K +$39.6K +1,499 +5%
WG
50
Winton Group
United Kingdom
$820K +$250K +9,471 +44%
1
2
3 4 5